Royalty Pharma delivered robust FY25 results, with double-digit growth in Royalty Receipts and Portfolio Receipts, and disciplined capital deployment. RPRX expanded its portfolio through $2.6B in new ...
The MarketWatch News Department was not involved in the creation of this content. Q4 2025 Run-Rate Daily Production of 25,627 Boe/d (6:1) Exceeds Mid-Point of Guidance Activity on Acreage Remains ...
Hosted on MSN
Sailfish Royalty announces Q4 2025 dividend
Sailfish Royalty ( (TSE:FISH)) just unveiled an announcement. Sailfish Royalty Corp. has announced a fourth quarterly cash dividend for 2025, amounting to US$0.0125 per common share, payable on July ...
DENVER, CO / ACCESS Newswire / February 3, 2026 / Vox Royalty Corp. (NASDAQ:VOXR)(TSX:VOXR) ("Vox" or the "Company"), a returns focused mining royalty and streaming company, is excited to announce ...
The company strengthened its production base and expanded reserves through material asset acquisitions and organic growth, enabling record-high year-end proved reserves. A 2025 credit agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results